BDNF and Alzheimer disease: Both exogenous BDNF administration and an exercise-induced increase in BDNF signaling can reduce the production of toxic Aβ peptides in transgenic AD-like APP/PS1 mice, thus corroborating the idea of a direct involvement of BDNF in non-amyloidogenic APP processing [140].